NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage
In this way, it is used to treat a variety of issues that would benefit from regeneration and restoration
Our team has seen the interest in research-grade BPC 157 Peptide skyrocket for this very reason
Spinach Leaf is a nutrient-dense leafy green packed with essential vitamins and minerals, including vitamins A, C, K, and folate, as well as iron and calcium
Histologic sampling in selected work suggested increased keratinocyte activity and dermal density patterns compatible with the matrix findings above
Which One Should You Use for Peptides
